COVID Nimbus variant NB.1.8.1 now accounts for 43% of U.S. cases. CDC models show growth in 27 states. ER visits rising. What high-risk people need to do now.

Parkinson’s is not one disease, and treating it as one may limit progress. In Bio-IT World, ASAP Managing Director and @aligningscience.com COO Sonya Dumanis, PhD, explores how biomarkers, molecular stratification, and open science can move the field toward precision medicine. 🔗: bit.ly/4hzVKWw

This week on The Genetics Podcast, Patrick is joined by Dr. Cara Altimus, CEO of BD², and Dr. Benjamin Neale, Associate Professor at Harvard Medical School and Massachusetts General Hospital. They...

“Failing to adopt a more inclusive concept of brain health represents a massive loss of human potential,” write Husseini K. Manji, Eric J. Nestler, and Patrick J. Kennedy.

GP2 is seeking a Project Manager with a strong scientific background to help coordinate global research activities and advance Parkinson’s disease genetics research.

ASAP's Protocols page supports open science by sharing experimental methods that make funded research replicable and useful to the broader scientific community.

Aligning Research to Impact Autism is a new initiative that connects emerging research, insights, and promising technologies from across scientific fields.

ASAP is devoted to accelerating the pace of discovery and informing the path to a cure for Parkinson’s disease.

Dr. Altimus discusses how BD² is uniting scientists, clinicians, and people with lived experience to close biological knowledge gaps and accelerate precision medicine in bipolar disorder.